2.53 (-%)
As of Nov 11, 2024
Source:
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | (617) 498-0020 |
Industry | manufacturing |
CEO | Martin Huber |
Website | www.mersana.com |